Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update

NEXT STORY
10x Genomics to Present at the 41st Annual Cowen Health Care Conference
PREV STORY
Clene Nanomedicine Presents Updated Interim Data from Phase 2 Multiple Sclerosis Programs at ACTRIMS Forum 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Abeona Therapeutics Receives FDA Breakthrough Therapy Designation for EB-101 Autologous Cell Therapy in Epidermolysis Bullosa

author_avatar
NASDAQ Market News

Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

author_avatar
NASDAQ Market News

RadNet Announces a Proposed Refinancing Transaction for its $611 Million Senior Secured Term Loan and $195 Million Senior Secured Revolving Credit Facility

author_avatar
NASDAQ Market News